Corgi Genomics & Precision Medicine ETF share price logo

Corgi Genomics & Precision Medicine ETF

$24.28

-0.67

(-2.68%)

as on

Corgi Genomics & Precision Medicine ETF Stock Performance

as on May 18, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $24.39
    $24.49
    downward going graph

    -0.45%

    Downside

    0.86%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Corgi Genomics & Precision Medicine ETF share price movements today

Previous Close
$24.95
Open
$24.49
Upper Circuit
-
Lower Circuit
-
Market Cap
$-
Volume
26.9K
Day's Low - High
$24.39 - $24.49

Corgi Genomics & Precision Medicine ETF Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %

Corgi Genomics & Precision Medicine ETF Fundamentals

Expense Ratio0%
Avg. PE ratioNA
Avg. PB ratioNA
AUM₹25,09,37,790.00

About Corgi Genomics & Precision Medicine ETF

Aevi Genomic Medicine, Inc., a clinical stage biopharmaceutical company, researches and develops novel therapies for pediatric onset and life-altering diseases in the United States. Its lead product candidate is AEVI-002, an anti-LIGHT monoclonal antibody that is in Phase Ib clinical trial for use in severe pediatric onset Crohn's disease. The company also develops AEVI-005, a monoclonal antibody, which is in preclinical research program for the treatment of auto-immune pediatric disease. In addition, it focuses on evaluating the anti-seizure activity of AEVI-004 in a preclinical model as part of the National Institutes of Health Epilepsy Treatment Screening Program. It has a development and option agreement with Kyowa Hakko Kirin Co., Ltd. related to AEVI-002 and AEVI-005. The company was formerly known as Medgenics, Inc. and changed its name to Aevi Genomic Medicine, Inc. in December 2016. Aevi Genomic Medicine, Inc. was founded in 2000 and is based in Wayne, Pennsylvania. As of February 3, 2020, Aevi Genomic Medicine, LLC operates as a subsidiary of Cerecor Inc.
ExchangeCBOE

Frequently Asked Questions

What is Corgi Genomics & Precision Medicine ETF (GNMX) share price today?

Corgi Genomics & Precision Medicine ETF (GNMX) share price today is $24.28.

Can Indians buy Corgi Genomics & Precision Medicine ETF shares?

Yes, Indians can invest in the Corgi Genomics & Precision Medicine ETF (GNMX) from India.

With INDmoney, you can buy Corgi Genomics & Precision Medicine ETF at 0 brokerage. The step-by-step process is as follows:

• Open your zero cost US Stocks account and zero balance IND Super Saver Account Powered by SBM India Bank (this can be done in less than 3 minutes)

• Transfer funds to your US Stocks account using your IND Super Saver Account (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.

• Once funds are transferred successfully, you can buy Corgi Genomics & Precision Medicine ETF at zero transaction cost.

How can I buy Corgi Genomics & Precision Medicine ETF shares from India?

It is very easy to buy Corgi Genomics & Precision Medicine ETF from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Corgi Genomics & Precision Medicine ETF be purchased?

Yes, you can buy fractional shares of Corgi Genomics & Precision Medicine ETF with INDmoney app.

What are the documents required to start investing in Corgi Genomics & Precision Medicine ETF stocks?

To start investing in Corgi Genomics & Precision Medicine ETF, You will need the following documents:

• Proof of Identification (PAN, Aadhaar etc)

• Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND Super Saver Account powered by SBM Bank so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.